GlassScriptPhysician profile
Steven B Zelicof
NPI 1780614990
$101,706.82
in general payments reported to CMS, 2019-2025
35 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $4,328 · 2021: $1,081 · 2022: $1,266 · 2023: $2,064 · 2024: $661 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $3,073 · Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,487.50 |
| Travel and Lodging | $3,073.21 |
| Food and Beverage | $2,088.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $81,532.57 | 2019-2025 | Accolade, Mako, Motionsense Digital Goniometer |
| Globus Medical, INC. | $16,607.33 | 2023-2025 | Genflex2 Total Knee System, Actify 3d, Legacy Stelkast Knee |
| Smith+Nephew, INC. | $572.09 | 2019-2023 | Healicoil |
| Zimmer Biomet Holdings, INC. | $519.66 | 2019-2023 | Tapestry, Persona |
| Treace Medical Concepts, INC. | $285.33 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $282.49 | 2019-2025 | Euflexxa |
| Horizon Therapeutics Plc | $263.72 | 2019-2022 | |
| Depuy Synthes Sales INC. | $194.34 | 2019-2025 | Monovisc |
| Bioventus LLC | $131.50 | 2024-2025 | Durolane, Supartz Fx Sodium Hyaluronate, Gelsyn-3 |
| Pacira Therapeutics, INC. | $116.70 | 2019-2021 | |
| Encore Medical, LP | $113.68 | 2023 | Djo Surgical |
| Fidia Pharma USA INC. | $110.16 | 2019-2025 | Triluron, Hymovis |
| Nevro Corp. | $95.27 | 2020-2023 | Senza |
| Pacira Pharmaceuticals Incorporated | $81.25 | 2023-2024 | Iovera, Zilretta, Exparel |
| Ethicon US, LLC | $67.29 | 2020-2025 | Stratafix, Surgicel Nu-Knit |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $64.44 | 2021-2023 | Zynrelef |
| Ermi LLC | $62.11 | 2019 | |
| Curonix LLC | $60.48 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Convatec INC. | $52.25 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $50.49 | 2019-2022 | |
| Ibsa Pharma INC. | $47.17 | 2021-2022 | |
| Becton, Dickinson and Company | $45.95 | 2019 | |
| Gotham Surgical Solutions & Devices, INC. | $39.12 | 2025 | |
| Biocomposites INC | $37.64 | 2024 | |
| Sanofi-Aventis U.S. LLC | $37.23 | 2019-2020 | |
| Linkbio Corp | $36.48 | 2025 | |
| Si-Bone, INC. | $32.25 | 2025 | |
| Molnlycke Health Care US, LLC | $28.72 | 2019 | |
| Medtronic, INC. | $26.09 | 2022 | |
| Avanos Medical | $24.87 | 2019 | |
| Sanara Medtech INC. | $24.39 | 2022 | |
| Amgen INC. | $21.33 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2023 | Seglentis |
| Pfizer INC. | $13.58 | 2020 | |
| Zimvie INC. | $12.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Zelicof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.